1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics in the United States, October 2018 (p25)

Biotechnology Analysis & Statistics in the United States, October 2018 (p25)

Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

All regions

721-750 of about 3200 reports

Crohn’s Disease: Dynamic Market Forecast to 2026

Crohn’s Disease: Dynamic Market Forecast to 2026

  • $ 8495
  • Industry report
  • October 2018

Crohn’s Disease: Dynamic Market Forecast to 2026Summary2016 sales for the Crohn’s disease market is estimated to be approximately $9.0 billion across the 7MM, encompassing the US, the five major European ...

  • Industries : Pathology, Medical Biotechnology, Biopharmaceutical, Biopharmaceutical
  • Countries : World, United States
Abcodia Ltd - Product Pipeline Analysis, 2018 Update

Abcodia Ltd - Product Pipeline Analysis, 2018 Update

  • $ 750
  • Company report
  • October 2018

SummaryAbcodia Ltd (Abcodia) is a clinical stage company that offers commercial development of novel, scientifically validated tests for the early detection of cancer.The company offers Roca Test, a blood ...

  • Industries : Cancer
  • Countries : United States, United Kingdom
Asthma - Pipeline Review, H2 2018

Asthma - Pipeline Review, H2 2018

  • $ 2500
  • Company report
  • October 2018

Asthma - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Pipeline Review, H2 2018, provides an overview of the Asthma (Respiratory) ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2018

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • October 2018

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive Pulmonary Disease ...

  • Industries : Pathology, Chronic Disease, Pharmaceutical, Therapy
  • Countries : United States
Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • October 2018

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus (HPV) Associated ...

  • Industries : Pathology, Cancer, Healthcare, Therapy, Pharmaceutical
  • Countries : United States
Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2018

Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • October 2018

Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 ...

  • Industries : Pharmaceutical, Therapy, Pathology
  • Countries : United States
Anaplastic Astrocytoma Global Clinical Trials Review, H2, 2018

Anaplastic Astrocytoma Global Clinical Trials Review, H2, 2018

  • $ 2500
  • Industry report
  • October 2018

Anaplastic Astrocytoma Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, H2, 2018" provides an overview of Anaplastic ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World, United States
Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H2, 2018

Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H2, 2018

  • $ 2500
  • Industry report
  • October 2018

Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H2, 2018" ...

  • Industries : Cancer, Pathology, Therapy, Medical Biotechnology
  • Countries : World, United States
Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H2, 2018

Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H2, 2018

  • $ 2500
  • Industry report
  • October 2018

Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic ...

  • Industries : Cancer, Pathology
  • Countries : World, United States
Competitor Landscape: Rheumatoid Arthritis

Competitor Landscape: Rheumatoid Arthritis

  • $ 6400
  • Industry report
  • October 2018

Competitor Landscape: Rheumatoid ArthritisSummary"Competitor Landscape: Rheumatoid Arthritis", briefings contain evaluations of ongoing development activities within the Rheumatoid Arthritis (RA) disease ...

  • Industries : Medical Biotechnology, Pharmaceutical
  • Countries : United States, European Union
Competitor Landscape: Lupus

Competitor Landscape: Lupus

  • $ 6400
  • Industry report
  • October 2018

Competitor Landscape: LupusSummary"Competitor Landscape: Lupus", briefings contain evaluations of ongoing development activities within the market, together with analysis of current & potential future ...

  • Industries : Pharmaceutical, Biopharmaceutical, Biopharmaceutical, Medical Biotechnology
  • Countries : United States, European Union
Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2018

Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • October 2018

Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Amyotrophic Lateral Sclerosis - Pipeline Review, H2 ...

  • Industries : Mental Health, Pathology
  • Countries : United States
Osteoporosis - Pipeline Review, H2 2018

Osteoporosis - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • October 2018

Osteoporosis - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Osteoporosis - Pipeline Review, H2 2018, provides an overview of the ...

  • Industries : Chronic Disease, Pathology, Pharmaceutical, Therapy, Medical Biotechnology
  • Countries : United States, World, China, East Asia
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H2 2018

Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • October 2018

Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Clostridium ...

  • Industries : Pathology, Therapy, Pharmaceutical, Healthcare
  • Countries : United States
Bone Metastasis - Pipeline Review, H2 2018

Bone Metastasis - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • October 2018

Bone Metastasis - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Bone Metastasis - Pipeline Review, H2 2018, provides an overview of ...

  • Industries : Cancer, Therapy, Pathology, Pharmaceutical, Medical Biotechnology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, World, China
Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, Share & Trends Analysis Report By Treatment And Segment Forecasts, 2018 - 2025

Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, Share & Trends Analysis Report By Treatment And Segment Forecasts, 2018 - 2025

  • $ 4950
  • Industry report
  • October 2018

Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Size, Share & Trends Analysis Report By Treatment (Medication, Stem Cell Transplant, Blood Transfusion), And Segment Forecasts, 2018 - 2025The ...

  • Industries : Medical Biotechnology, Therapy, Pharmaceutical, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, World
Carbon Nanotubes Market by Type, Method, Application - Global Forecast to 2023

Carbon Nanotubes Market by Type, Method, Application - Global Forecast to 2023

  • $ 5650
  • Industry report
  • October 2018

The carbon nanotubes market is expected to grow at a CAGR of 16.70% between 2018 and 2023.The carbon nanotubes market is estimated to grow from USD 4.55 billion in 2018 to USD 9.84 billion by 2023, at ...

  • Industries : Industrial Biotechnology, Advanced Material, Biomaterial, Materials
  • Countries : North America, United States, World
Datamonitor Healthcare Strategy: Gene Therapy Commercialization – Opportunities and Barriers

Datamonitor Healthcare Strategy: Gene Therapy Commercialization – Opportunities and Barriers

  • $ 2995
  • Industry report
  • October 2018

OverviewCommercialization of modern-day gene therapies is now a reality. Next-generation modalities such as chimeric antigen receptor T-cell (CAR- T) therapies are fully in launch mode in the US, with ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States
Selecta Biosciences Inc (SELB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Selecta Biosciences Inc (SELB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummarySelecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases.The company’s pipeline ...

  • Industries : Medical Biotechnology, Pharmaceutical, Therapy, Biopharmaceutical, Biopharmaceutical
  • Countries : United States
Dermira Inc (DERM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Dermira Inc (DERM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryDermira Inc (Dermira) is a biopharmaceutical company that identifies, develops and commercializes therapeutic solutions for the treatment of dermatologic diseases, such as hyperhidrosis, acne vulgaris ...

  • Industries : Pathology, Medical Biotechnology, Pharmaceutical
  • Countries : United States
ARCA biopharma Inc (ABIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ARCA biopharma Inc (ABIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases.The company’s product candidate include Gencaro, a mild vasodilato ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical
  • Countries : United States
Adaptimmune Therapeutics Plc (ADAP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Adaptimmune Therapeutics Plc (ADAP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryAdaptimmune Therapeutics Plc (Adaptimmune), formerly Adaptimmune Therapeutics Limited, is a clinical stage biopharmaceutical company that develops innovative T-cell therapy products for the treatment ...

  • Industries : Therapy, Medical Biotechnology, Pharmaceutical, Biopharmaceutical, Biopharmaceutical
  • Countries : United States
Realm Therapeutics Plc (RLM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Realm Therapeutics Plc (RLM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryRealm Therapeutics Plc (Realm Therapeutics), formerly PuriCore Plc is a biopharmaceutical company that develops small molecule therapies for diseases.The company uses its immunomodulatory technology ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States
NADPH Oxidase 4 (Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NAD(P)H Oxidase or NOX4 or EC 1.6.3.) - Pipeline Review, H2 2018

NADPH Oxidase 4 (Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NAD(P)H Oxidase or NOX4 or EC 1.6.3.) - Pipeline Review, H2 2018

  • $ 3500
  • Company report
  • October 2018

NADPH Oxidase 4 (Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NAD(P)H Oxidase or NOX4 or EC 1.6.3.) - Pipeline Review, H2 2018SummaryNADPH Oxidase 4 (Kidney Oxidase 1 ...

  • Countries : World, United States
InVitae Corp (NVTA) - Medical Equipment - Deals and Alliances Profile

InVitae Corp (NVTA) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryInvitae Corp (Invitae), formerly Locus Development Inc, is a genetic information company which processes DNA-containing samples, analyzes information about patient-specific genetic variation and ...

  • Industries : Diagnostics, Medical Biotechnology, Healthcare, Biotechnology
  • Countries : United States
Ascendis Pharma AS (ASND) - Medical Equipment - Deals and Alliances Profile

Ascendis Pharma AS (ASND) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryAscendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services.The company’s pipeline products include transcon growth hormone, transcon PTH, ...

  • Industries : Pharmaceutical, Medical Biotechnology, Medical Supply, Medical Device
  • Countries : United States
Genocea Biosciences Inc (GNCA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Genocea Biosciences Inc (GNCA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryGenocea Biosciences Inc (Genocea), formerly GenoceaInc, is a cancer vaccines provider.The company discovers and develops T cell-directed vaccines and immunotherapies to treat infectious diseases ...

  • Industries : Medical Biotechnology, Therapy, Pharmaceutical, Biopharmaceutical, Biopharmaceutical
  • Countries : United States
ReproCELL Inc (4978) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ReproCELL Inc (4978) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryReproCELL Inc (ReproCELL) is a biotechnology company that develops and commercializes stem cell technologies.The company offers products in divisions such as research reagents, cultivation materials, ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical
  • Countries : Japan, United States
TaiMed Biologics Inc (4147) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

TaiMed Biologics Inc (4147) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryTaiMed Biologics Inc (TMB) is a biotechnology company that provides novel medicines for the prevention and treatment of viral infectious diseases.The company provides pipeline products such as TMB-355, ...

  • Industries : Medical Biotechnology, Pharmaceutical, Biopharmaceutical, Biopharmaceutical, Therapy
  • Countries : United States, Taiwan, Europe
Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2018

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2018

  • $ 3500
  • Company report
  • October 2018

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2018SummaryGranulocyte Macrophage Colony Stimulating ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Cancer, Pharmaceutical, Pathology, Therapy
  • Countries : United States, World

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on